Integrative genomic analyses of APOBEC-mutational signature, expression and germline deletion of APOBEC3 genes, and immunogenicity in multiple cancer types

Published on Dec 1, 2019in BMC Medical Genomics2.568
· DOI :10.1186/s12920-019-0579-3
Zhishan Chen (VUMC: Vanderbilt University Medical Center), Wanqing Wen52
Estimated H-index: 52
(VUMC: Vanderbilt University Medical Center)
+ 6 AuthorsXingyi Guo24
Estimated H-index: 24
(VUMC: Vanderbilt University Medical Center)
Although APOBEC-mutational signature is found in tumor tissues of multiple cancers, how a common germline APOBEC3A/B deletion affects the mutational signature remains unclear. Using data from 10 cancer types generated as part of TCGA, we performed integrative genomic and association analyses to assess inter-relationship of expressions for isoforms APOBEC3A and APOBEC3B, APOBEC-mutational signature, germline APOBEC3A/B deletions, neoantigen loads, and tumor infiltration lymphocytes (TILs). We found that expression level of the isoform uc011aoc transcribed from the APOBEC3A/B chimera was associated with a greater burden of APOBEC-mutational signature only in breast cancer, while germline APOBEC3A/B deletion led to an increased expression level of uc011aoc in multiple cancer types. Furthermore, we found that the deletion was associated with elevated APOBEC-mutational signature, neoantigen loads and relative composition of T cells (CD8+) in TILs only in breast cancer. Additionally, we also found that APOBEC-mutational signature significantly contributed to neoantigen loads and certain immune cell abundances in TILs across cancer types. These findings reveal new insights into understanding the genetic, biological and immunological mechanisms through which APOBEC genes may be involved in carcinogenesis, and provide potential genetic biomarker for the development of disease prevention and cancer immunotherapy.
  • References (48)
  • Citations (1)
📖 Papers frequently viewed together
7 Authors (Xingyi Guo, ..., Wei Zheng)
3 Citations
10 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Amélie Boichard (University of California, Berkeley)H-Index: 4
#2Timothy V. PhamH-Index: 1
Last. Razelle Kurzrock (University of California, Berkeley)H-Index: 99
view all 9 authors...
ABSTRACTTumor-associated neo-antigens are mutated peptides that allow the immune system to recognize the affected cell as foreign. Cells carrying excessive mutation load often develop mechanisms of tolerance. PD-L1/PD-1 checkpoint immunotherapy is a highly promising approach to overcome these protective signals and induce tumor shrinkage. Yet, the nature of the neo-antigens driving those beneficial responses remains unclear. Here, we show that APOBEC-related mutagenesis – a mechanism at the cros...
2 CitationsSource
#1Xingyi Guo (Vandy: Vanderbilt University)H-Index: 24
#2Weiqiang Lin (ZJU: Zhejiang University)H-Index: 1
Last. Wei Zheng (Vandy: Vanderbilt University)H-Index: 73
view all 17 authors...
Genome-wide association studies (GWASs) have identified more than 150 common genetic loci for breast cancer risk. However, the target genes and underlying mechanisms remain largely unknown. We conducted a cis -expression quantitative trait loci ( cis -eQTL) analysis using normal or tumor breast transcriptome data from the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC), The Cancer Genome Atlas (TCGA), and the Genotype-Tissue Expression (GTEx) project. We identified a tota...
9 CitationsSource
#1Shixiang Wang (CAS: Chinese Academy of Sciences)H-Index: 2
#2Mingming Jia (CAS: Chinese Academy of Sciences)H-Index: 1
Last. Xue-Song Liu (ShanghaiTech University)H-Index: 14
view all 4 authors...
Non-small cell lung cancer (NSCLC) is known to carry heavy mutation load. Besides smoking, cytidine deaminase APOBEC3B plays a key role in the mutation process of NSCLC. APOBEC3B is also reported to be upregulated and predicts bad prognosis in NSCLC. However, targeting APOBEC3B high NSCLC is still a big challenge. Here we show that APOBEC3B upregulation is significantly associated with immune gene expression, and APOBEC3B expression positively correlates with known immunotherapy response biomark...
23 CitationsSource
#1Xingyi Guo (VUMC: Vanderbilt University Medical Center)H-Index: 24
#2Jiajun Shi (VUMC: Vanderbilt University Medical Center)H-Index: 3
Last. Jirong Long (VUMC: Vanderbilt University Medical Center)H-Index: 51
view all 14 authors...
8 CitationsSource
#1Liv Beathe GansmoH-Index: 6
#2Paal Romundstad (NTNU: Norwegian University of Science and Technology)H-Index: 5
Last. Stian Knappskog (University of Bergen)H-Index: 27
view all 7 authors...
The study was supported by grants from the Bergen Research Foundation, the Norwegian Cancer Society’s Pink Ribbon campaign, the Norwegian Research Council and the Norwegian Health Region West.
10 CitationsSource
#1Nicolas Jacquelot (French Institute of Health and Medical Research)H-Index: 11
#2María Paula Roberti (French Institute of Health and Medical Research)H-Index: 9
Last. Laurence ZitvogelH-Index: 115
view all 50 authors...
Immune checkpoint blockers (ICB) have become pivotal therapies in the clinical armamentarium against metastatic melanoma (MMel). Given the frequency of immune related adverse events and increasing use of ICB, predictors of response to CTLA-4 and/or PD-1 blockade represent unmet clinical needs. Using a systems biology-based approach to an assessment of 779 paired blood and tumor markers in 37 stage III MMel patients, we analyzed association between blood immune parameters and the functional immun...
52 CitationsSource
#2Abctb Investigators (University of Melbourne)H-Index: 1
#3kConFab (Peter MacCallum Cancer Centre)H-Index: 2
Last. Aocs Investigators (University of Melbourne)H-Index: 1
view all 3 authors...
Breast cancer risk is influenced by rare coding variants in susceptibility genes, such as BRCA1, and many common, mostly non-coding variants. However, much of the genetic contribution to breast cancer risk remains unknown. Here we report the results of a genome-wide association study of breast cancer in 122,977 cases and 105,974 controls of European ancestry and 14,068 cases and 13,104 controls of East Asian ancestry1. We identified 65 new loci that are associated with overall breast cancer risk...
239 CitationsSource
#2Wojciech KluzniakH-Index: 8
Last. Piotr KozlowskiH-Index: 16
view all 12 authors...
// Katarzyna Klonowska 1 , Wojciech Kluzniak 2 , Bogna Rusak 2 , Anna Jakubowska 2 , Magdalena Ratajska 3 , Natalia Krawczynska 3 , Danuta Vasilevska 4 , Karol Czubak 1 , Marzena Wojciechowska 1 , Cezary Cybulski 2 , Jan Lubinski 2 and Piotr Kozlowski 1 1 Department of Molecular Genetics, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland 2 Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland 3 De...
3 CitationsSource
#1Sathana Dushyanthen (Peter MacCallum Cancer Centre)H-Index: 7
#2Zhi Ling Teo (University of Melbourne)H-Index: 14
Last. Sherene Loi (University of Melbourne)H-Index: 56
view all 18 authors...
The presence of tumor-infiltrating lymphocytes in triple-negative breast cancers is correlated with improved outcomes. Ras/MAPK pathway activation is associated with significantly lower levels of tumor-infiltrating lymphocytes in triple-negative breast cancers and while MEK inhibition can promote recruitment of tumor-infiltrating lymphocytes to the tumor, here we show that MEK inhibition adversely affects early onset T-cell effector function. We show that α-4-1BB and α-OX-40 T-cell agonist antib...
18 CitationsSource
#1Dung T. Le (Johns Hopkins University)H-Index: 23
#2Jennifer N. Durham (Johns Hopkins University)H-Index: 4
Last. Luis A. Diaz (Johns Hopkins University)H-Index: 92
view all 46 authors...
The genomes of cancers deficient in mismatch repair contain exceptionally high numbers of somatic mutations. In a proof-of-concept study, we previously showed that colorectal cancers with mismatch repair deficiency were sensitive to immune checkpoint blockade with antibodies to programmed death receptor–1 (PD-1). We have now expanded this study to evaluate the efficacy of PD-1 blockade in patients with advanced mismatch repair–deficient cancers across 12 different tumor types. Objective radiogra...
995 CitationsSource
Cited By1
PURPOSE: APOBEC3A and APOBEC3B cytidine deaminases have been implicated in the pathogenesis of multiple cancers, including breast cancer (BC). A germline deletion linking APOBEC3A and APOBEC3B loci (A3A/B) has been associated with higher APOBEC-mediated mutational burden, but its association with BC risk have been controversial. Therefore, this study investigated the association between A3A/B and BC susceptibility and clinical presentation in a Brazilian cohort. METHODS: A3A/B deletion was evalu...
#1Nicole E. Mealey (U of C: University of Calgary)
#2Dylan E. O'Sullivan (Queen's University)H-Index: 5
Last. Darren R. Brenner (AHS: Alberta Health Services)H-Index: 9
view all 7 authors...
BACKGROUND: The incidence of breast cancer among young women (aged 40 years) using data from The Cancer Genome Atlas. We examined mutated genes, mutational load, and types of mutations. We used complementary R packages "deconstructSigs" and "SomaticSignatures" to extract mutational signatures. A recursively partitioned mixture model was used to identify whether combinations of mutational signatures were related to age of onset. RESULTS: Older patients had a higher proportion of mutations in PIK3...
#1Fangdong Li (AAU: Anhui Agricultural University)H-Index: 6
#2Wei Tong (AAU: Anhui Agricultural University)H-Index: 3
Last. Chaoling Wei (AAU: Anhui Agricultural University)H-Index: 14
view all 4 authors...
Tea is the oldest and among the world’s most popular non-alcoholic beverages, which has important economic, health and cultural values. Tea is commonly produced from the leaves of tea plants (Camellia sinensis), which belong to the genus Camellia of family Theaceae. In the last decade, many studies have generated the transcriptomes of tea plants at different developmental stages or under abiotic and/or biotic stresses to investigate the genetic basis of secondary metabolites that determine tea q...